doctitl nation cancer institut opportun cooper research agreement crada scientif commerci develop monoclon antibodi tumor specif growth factor diagnosi prognosi premalign lesion cancer doctitl agenc agenc nation institut health ph dhh agenc action action notic action summari summari nation cancer institut nci seek pharmaceut biotechnolog compani effect pursu scientif commerci gener develop panel monoclon antibodi epiderm growth factor egf relat peptid cripto 1 cr1 project scientif import cr1 protein exhibit structur homolog egf transform growth factor tgf gene famili peptid cr1 might function growth factor growth inhibitor therefor cr1 may import autocrin paracrin modul process tumor cell growth wound repair neovascular inflamm nci success isol clone gene encod cr1 egf relat peptid growth factor function egf receptor nci also obtain rabbit anti peptid polyclon antibodi detect express cr1 formalin fix paraffin embed human tissu section cr1 shown preferenti differenti express sever differ human premalign lesion cancer select sponsor purifi recombin cr1 protein use materi immunogen gener anti cr1 monoclon antibodi use diagnosi prognosi human cancer summari address address inquiri propos regard opportun address either michael christini mark noel tel 3014960477 fax 3014022117 offic technolog develop nation cancer institut bldg 31 room 4a49 nih 9000 rockvil pike bethesda md 20892 address date date propos must receiv address 5 p septemb 9 1994 date supplem supplementari inform nci seek pharmaceut biotechnolog compani obtain licens accord requir regul govern transfer govern develop agent 37 cfr part 404 purifi recombin cr1 protein patent pend issu util purifi recombin cr1 protein immunogen gener panel mous monoclon antibodi immunoreact cr1 protein detect immunoperoxidas stain use rabbit anti peptid polyclon cr1 antibodi major human colon cancer breast cancer gastric cancer pancreat cancer littl stain detect surround noninvolv colon breast gastric epitheli cell addit major premalign colon adenoma breast ductal carcinoma situ gastric intestin metaplasia express immunoreact cr1 recombin cr1 protein gener use yeast express vector pichia pastori partial purifi protein obtain protein well synthet refold peptid correspond egf like domain cr1 mitogen human breast cancer cell yet fail bind egf receptor type receptor tyrosin kinas express cr1 antisens mrna use recombin replic defect retrovir express vector colon cancer cell express cr1 inhibit growth cell vivo nude mice order util diagnost therapeut potenti cr1 necessari purifi signific amount recombin cr1 protein fulli defin biolog properti identifi receptor function addit mous monoclon antibodi purifi cr1 recombin protein expedit screen studi cr1 express human premalign lesion cancer exhibit specif sensit detect cr1 tissu immunocytochemistri icc tissu extract serum sampl elisa role nation cancer institut divis cancer biolog diagnosi center includ 1 nci provid express vector encod cr1 use produc cr1 e coli 2 nci provid express vector encod cr1 yeast pichia pastori contain sever milligram recombin cr1 protein 3 nci provid rabbit polyclon anti cr1 antibodi monitor cr1 recoveri purif yeast condit medium 4 nci assay purifi recombin cr1 protein bioactiv 5 nci screen anti cr1 monoclon antibodi reactiv western blot analysi nativ cr1 protein cr1 posit human embryon carcinoma colon carcinoma cell role success corpor partner includ 1 obtain background licens appropri field use relev govern patent right 2 purifi homogen 3050 milligram cr1 pichia pastori condit medium 3 provid purifi recombin cr1 protein 4 util purifi recombin cr1 protein gener mous anti cr1 monoclon antibodi 5 screen anti cr1 monoclon antibodi specif reactiv sensit toward recombin cr1 protein 6 ascertain whether monoclon anti cr1 antibodi detect nativ cr1 protein cr1 posit human colorect embryon carcinoma cell radioimmunoprecipit analysi elisa 7 determin whether anti cr1 antibodi use icc formalin fix paraffin embed tissu known cr1 express 8 provid fund support postdoctor fellow associ expens criteria choos collabor compani includ 1 abil obtain background licens relev patent right 2 experi produc purifi recombin protein particularli growth factor cytokin 3 experi gener screen monoclon antibodi 4 willing cooper nci collect evalu data 5 willing cost share laboratori studi 6 agreement bound dhh rule involv use human anim subject human tissu 7 provis equit distribut patent right invent gener right ownership retain organ employ free licens govern compani employe sole inventor 2 exclus nonexclus licens compani term appropri govern employe sole inventor date august 8 1994 supplem signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9419943 file 81594 8 45 frfile bill bill code 414001p bill